European Biotechnological and Pharmaceutical Patenting in 2015 New Laws & Amendments, Competition, and Litigation

Joe has a degree and Ph.D. in Chemistry from the University of Durham, UK.  His PhD project focussed on catalyst recycling in industrial processes.  He is an active committee member in the Royal Society of Chemistry Law Group. Joe joined Mewburn Ellis LLP in 2007, and is a qualified UK and European Patent Attorney.

Joe handles patent work predominantly in the field of chemical field and medical devices, with particular experience in the fields of small molecule pharmaceuticals, such as protein kinase inhibitors, molecular imaging molecules, implantable biomedical devices and polymer coatings for medical devices.  He deals mainly with patent drafting, prosecution, and EPO opposition (revocation) and appeal work, as well as freedom to operate, validity and infringement opinion work. Joe works for a range of clients, including SMEs, research foundations and large UK and overseas companies.

Glyn has a patent practice that spans a wide range of biotechnology subject-matter. The majority of his work involves the drafting and prosecution of patent applications, and the handling of post-grant opposition proceedings, before the European Patent Office. In recent years, he has handled numerous EPO oppositions and appeals involving biologics and cellular therapies, in addition to supporting litigation in the High Court of England & Wales. These high-value cases have led to a deepening interest in the interplay between patents, SPCs and regulatory issues. 

Glyn studied Biochemistry at the University of Bath, graduating with a first class degree and the Bill Whish Prize for Biochemistry. During his degree, Glyn completed two six-month research projects. The first project was an investigation into Nuclear Localisation Signals, at Emory University’s Department of Biochemistry (Atlanta, USA). The second project related to vesicle trafficking mechanisms, at the Institute for Molecular Bioscience (University of Queensland, Australia). Glyn also carried out bioinformatic research into the factors responsible for stabilising thermophilic enzymes, as his final year research project.

Glyn entered the patent profession in 2003 and joined Carpmaels in 2009. During qualification, he was awarded the 2007 Strode Prize for obtaining the highest score in the UK Advanced Patent Practice exam.